Panobinostat
Showing 26 - 50 of 149
MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)
Completed
- Myelodysplastic Syndromes (MDS)
- +2 more
- Panobinostat
-
Nagoya-city, Aichi, Japan
- +5 more
Dec 16, 2020
MDS (MDS) Trial in United States (Panobinostat)
Terminated
- Myelodysplastic Syndromes (MDS)
- Panobinostat
-
Fort Myers, Florida
- +6 more
Nov 18, 2021
Acute Myeloid Leukemia (AML) Trial in Germany, Spain, United States (Panobinostat)
Completed
- Acute Myeloid Leukemia (AML)
- Panobinostat
-
Stanford, California
- +9 more
Dec 16, 2020
Classical Hodgkin's Lymphoma Trial in Worldwide (Panobinostat)
Completed
- Classical Hodgkin's Lymphoma
- Panobinostat
-
Duarte, California
- +45 more
Jul 26, 2021
HER-2 Positive Breast Cancer, Metastatic Breast Cancer Trial in Worldwide (IV LBH589, Oral LBH589, trastuzumab)
Completed
- HER-2 Positive Breast Cancer
- Metastatic Breast Cancer
- IV LBH589
- +3 more
-
Mobile, Alabama
- +6 more
Dec 16, 2020
Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)
Terminated
- Chronic Myeloid Leukemia in Chronic Phase
-
Bruxelles, Belgium
- +9 more
Jul 14, 2021
Neuroendocrine Tumors Trial in Madison (panobinostat (LBH589))
Terminated
- Neuroendocrine Tumors
- panobinostat (LBH589)
-
Madison, WisconsinUniversity of Wisconsin, Madison
Nov 19, 2019
Multiple Myeloma Trial in Worldwide (panobinostat capsules, bortezomib injection, dexamethasone tablets)
Active, not recruiting
- Multiple Myeloma
- panobinostat capsules
- +2 more
-
Fayetteville, Arkansas
- +79 more
Mar 15, 2021
Multiple Myeloma, Kahler Disease, Plasma-Cell Myeloma Trial in Cleveland (Panobinostat, Dexamethasone, MLN9708)
Completed
- Multiple Myeloma
- +3 more
- Panobinostat
- +2 more
-
Cleveland, Ohio
- +1 more
Dec 10, 2019
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (Panobinostat (LBH589), 5-Azacytidine)
Completed
- Myelodysplastic Syndromes
- +2 more
- Panobinostat (LBH589)
- 5-Azacytidine
-
Augusta, Georgia
- +37 more
Jul 20, 2020
Melanoma, Non Small Cell Lung Cancer Trial (PDR001, Panobinostat)
Withdrawn
- Melanoma
- Non Small Cell Lung Cancer
- PDR001
- Panobinostat
- (no location specified)
Oct 1, 2019
Cutaneous T-Cell Lymphoma Trial in United States (Panobinostat)
Terminated
- Cutaneous T-Cell Lymphoma
- Panobinostat
-
Birmingham, Alabama
- +17 more
Aug 16, 2021
Multiple Myeloma Trial in Worldwide (Panobinostat)
No longer available
- Multiple Myeloma
- Panobinostat
-
Innsbruck, Tyrol, Austria
- +39 more
Apr 6, 2020
Diffuse Large B-cell Lymphoma Trial in Italy (Panobinostat)
Completed
- Diffuse Large B-cell Lymphoma
- Panobinostat
-
Alessandria, Italy
- +9 more
Nov 4, 2019
Glioma, Diffuse Intrinsic Pontine Glioma Trial in Ann Arbor (Panobinostat, Everolimus)
Withdrawn
- Glioma
- Diffuse Intrinsic Pontine Glioma
- Panobinostat
- Everolimus
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Aug 14, 2019
Relapse/Refractory Multiple Myeloma Trial in Japan (LBH589 (panobinostat), bortezomib, dexamethasone)
Completed
- Relapse/Refractory Multiple Myeloma
- LBH589 (panobinostat)
- +2 more
-
Nagoya-city, Aichi, Japan
- +19 more
Oct 28, 2019